← Open Payments lookup

MAGALY ALONSO: Open Payments

NPI 1861458226 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,638 in 72 payments from 14 companies in 2025. Trend: 2023 $1,463 · 2024 $1,311 · 2025 $1,638

Food & beverage: $1,638
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.18$387
ABBVIE INC.17$373
Takeda Pharmaceuticals U.S.A., Inc.13$225
Vanda Pharmaceuticals Inc.4$101
Otsuka America Pharmaceutical, Inc.4$100
ACADIA Pharmaceuticals Inc1$91
Axsome Therapeutics, Inc.3$84
E.R. Squibb & Sons, L.L.C.3$81
Lundbeck LLC3$71
Teva Pharmaceuticals USA, Inc.2$39

Products named: INGREZZA, VRAYLAR, TRINTELLIX, REXULTI, NUPLAZID, Auvelity, COBENFY, FANAPT.

Industry payments across FL — which companies pay providers there.